Cargando…
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
Botulinum toxin type B (BoNT-B), known as Myobloc(®) in the United States and as Neurobloc(®) in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investigating its efficacy and safety, as well as...
Autores principales: | Campanati, Anna, Diotallevi, Federico, Radi, Giulia, Martina, Emanuela, Marconi, Barbara, Bobyr, Ivan, Offidani, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966525/ https://www.ncbi.nlm.nih.gov/pubmed/36828461 http://dx.doi.org/10.3390/toxins15020147 |
Ejemplares similares
-
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature
por: Campanati, Anna, et al.
Publicado: (2022) -
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
por: Martina, Emanuela, et al.
Publicado: (2021) -
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption
por: Campanati, Anna, et al.
Publicado: (2019) -
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities
por: Campanati, Anna, et al.
Publicado: (2022) -
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
por: Campanati, Anna, et al.
Publicado: (2021)